Breaking News

Tag Archives: ANDA

Ranbaxy Laboratories receives USFDA approval

Ranbaxy Laboratories has received an approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Quinapril Hydrochloride & Hydrochlorothiazide (Quinapril – THCTZ) tablets, 10mg / 12.5mg, 20mg / 12.5mg and 20mg / 25mg. ... Read More »